Evaluation of hypertension in children and adolescents
- Tej K Mattoo, MD, DCH, FRCP
Tej K Mattoo, MD, DCH, FRCP
- Section Editor — Pediatric Nephrology
- Professor of Pediatrics
- Wayne State University School of Medicine
It has become clear that hypertension (HTN) begins in childhood and adolescence, and that it contributes to the early development of cardiovascular disease (CVD). The supporting data include clinical studies that demonstrate cardiovascular structural and functional changes in children with HTN, and autopsy studies that have shown an association of blood pressure (BP) with atherosclerotic changes in the aorta and heart in children and young adults. (See "Definition and diagnosis of hypertension in children and adolescents" and "Risk factors and development of atherosclerosis in childhood", section on 'Hypertension'.)
In hypertensive adults, multiple randomized trials have shown that reduction of BP by antihypertensive therapy reduces cardiovascular morbidity and mortality. The magnitude of the benefit increases with the severity of the HTN. (See "Hypertension: Who should be treated?".)
Based upon these observations, identifying children with HTN and successfully treating their HTN should have an important impact on long-term outcomes of CVD. One of the most important components of the successful management of childhood HTN is determining whether or not there is an underlying cause that is amenable to treatment.
The evaluation of children with HTN will be reviewed here. The epidemiology, etiology, diagnosis, and treatment of childhood hypertension are discussed separately. (See "Epidemiology, risk factors, and etiology of hypertension in children and adolescents" and "Definition and diagnosis of hypertension in children and adolescents" and "Nonemergent treatment of hypertension in children and adolescents".)
In addition, the evaluation for hypertensive emergency is presented elsewhere. (See "Approach to hypertensive emergencies and urgencies in children".)
- National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114:555.
- Wyszyńska T, Cichocka E, Wieteska-Klimczak A, et al. A single pediatric center experience with 1025 children with hypertension. Acta Paediatr 1992; 81:244.
- Flynn J, Zhang Y, Solar-Yohay S, Shi V. Clinical and demographic characteristics of children with hypertension. Hypertension 2012; 60:1047.
- Flynn JT. Differentiation between primary and secondary hypertension in children using ambulatory blood pressure monitoring. Pediatrics 2002; 110:89.
- Seeman T, Palyzová D, Dusek J, Janda J. Reduced nocturnal blood pressure dip and sustained nighttime hypertension are specific markers of secondary hypertension. J Pediatr 2005; 147:366.
- Lurbe E, Agabiti-Rosei E, Cruickshank JK, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 2016; 34:1887.
- Marcus CL, Greene MG, Carroll JL. Blood pressure in children with obstructive sleep apnea. Am J Respir Crit Care Med 1998; 157:1098.
- Enright PL, Goodwin JL, Sherrill DL, et al. Blood pressure elevation associated with sleep-related breathing disorder in a community sample of white and Hispanic children: the Tucson Children's Assessment of Sleep Apnea study. Arch Pediatr Adolesc Med 2003; 157:901.
- Li AM, Au CT, Ho C, et al. Blood pressure is elevated in children with primary snoring. J Pediatr 2009; 155:362.
- Horne RS, Yang JS, Walter LM, et al. Elevated blood pressure during sleep and wake in children with sleep-disordered breathing. Pediatrics 2011; 128:e85.
- Brady TM, Fivush B, Flynn JT, Parekh R. Ability of blood pressure to predict left ventricular hypertrophy in children with primary hypertension. J Pediatr 2008; 152:73.
- Ramaswamy P, Patel E, Fahey M, et al. Electrocardiographic predictors of left ventricular hypertrophy in pediatric hypertension. J Pediatr 2009; 154:106.
- Belsha CW, Wells TG, McNiece KL, et al. Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension. Am J Hypertens 1998; 11:410.
- Sorof JM, Alexandrov AV, Cardwell G, Portman RJ. Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 2003; 111:61.
- Hanevold C, Waller J, Daniels S, et al. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics 2004; 113:328.
- Daniels SR, Loggie JM, Khoury P, Kimball TR. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 1998; 97:1907.
- Schieken RM, Schwartz PF, Goble MM. Tracking of left ventricular mass in children: race and sex comparisons: the MCV Twin Study. Medical College of Virginia. Circulation 1998; 97:1901.
- Gidding SS. The aging of the cardiovascular system: when should children be treated like adults? J Pediatr 2002; 141:159.
- Kapur G, Ahmed M, Pan C, et al. Secondary hypertension in overweight and stage 1 hypertensive children: a Midwest Pediatric Nephrology Consortium report. J Clin Hypertens (Greenwich) 2010; 12:34.
- Viazzi F, Antolini L, Giussani M, et al. Serum uric acid and blood pressure in children at cardiovascular risk. Pediatrics 2013; 132:e93.
- Feig DI, Nakagawa T, Karumanchi SA, et al. Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int 2004; 66:281.
- Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA 2007; 298:874.
- Ahmed M, Eggleston D, Kapur G, et al. Dimercaptosuccinic acid (DMSA) renal scan in the evaluation of hypertension in children. Pediatr Nephrol 2008; 23:435.
- Friedman K, Wallis T, Maloney KW, et al. An unusual cause of pediatric hypertension. J Pediatr 2007; 151:206.
- Dillon MJ, Ryness JM. Plasma renin activity and aldosterone concentration in children. Br Med J 1975; 4:316.
- Guzzetta PC, Potter BM, Ruley EJ, et al. Renovascular hypertension in children: current concepts in evaluation and treatment. J Pediatr Surg 1989; 24:1236.
- Chhadia S, Cohn RA, Vural G, Donaldson JS. Renal Doppler evaluation in the child with hypertension: a reasonable screening discriminator? Pediatr Radiol 2013; 43:1549.
- Castelli PK, Dillman JR, Kershaw DB, et al. Renal sonography with Doppler for detecting suspected pediatric renin-mediated hypertension - is it adequate? Pediatr Radiol 2014; 44:42.
- Castelli PK, Dillman JR, Smith EA, et al. Imaging of renin-mediated hypertension in children. AJR Am J Roentgenol 2013; 200:W661.
- Primary versus secondary hypertension
- Comorbid risk factors and diseases
- INITIAL EVALUATION
- History and physical examination
- - Secondary versus primary hypertension
- - CVD risk factors
- - Physical findings of end-organ damage
- Laboratory evaluation and imaging
- FURTHER EVALUATION
- Primary hypertension
- Secondary hypertension
- - Renal imaging
- - Plasma renin and aldosterone activity
- - Plasma and urine catecholamines
- - Renovascular imaging
- Our approach
- INFORMATION FOR PATIENTS
- SUMMARY AND RECOMMENDATIONS